Dentsply Sirona Q4 net loss $146M on $144M impairments; eliminates dividend, guides FY2026 adj EPS $1.40-$1.50

DENTSPLY SIRONA Inc.

2025-FY EPS reported -$3.00 revenue$3,680,000,000

Q4 net sales $961M (+6.2% reported, +2.5% constant currency); reported diluted EPS ($0.74) from $144M impairments.
FY2025 net sales $3.68B (-3.0%), adjusted EPS $1.60. FY2026 guidance: sales $3.5-3.6B, adjusted EPS $1.40-1.50.
Restructuring plan approved: $55-65M charges, ~$120M annual savings, reinvested in growth initiatives.
Quarterly dividend eliminated; capital redeployed to debt retirement and share repurchases.
Appointed three new board members (Forbes, McKeon, Zurbay); new distribution agreements with Patterson, Benco, Burkhart, A-dec.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.